In order to investigate the O-mannosyltransferase involved in the initial O-mannosylation of glycoproteins in Saccharomyces cerevisiae, a photoactive hexapeptide, [125I]-N-(4-azido-2,3,5,6-tetrafluorobenzoyl)-3-iodo-Tyr-Asn-Pro-T hr-Ser-Val ([125I]azidoTyr-peptide), was synthesized by solid-phase techniques using a new photoactive cross-linking reagent, N-(4-azido-2,3,5,6-tetrafluorobenzoyl)tyrosine, and resin-bound Asn-Pro-Thr(tBu)-Ser(tBu)-Val. When this modified hexapeptide substrate was incubated with O-mannosyltransferase preparations, the hexapeptide was an acceptor of [14C]-mannose from dolichol phosphate-[14C]mannose. After partially purifying the O-mannosyltransferase and photolabeling these enzyme preparations with [125I]azidoTyr-peptide, a ca. 82-kDa protein was shown to be the only apparent photolabeled protein that was protected by unmodified hexapeptide. This ca. 82-kDa protein may be the catalytic subunit of the O-mannosyltransferase. The susceptibility of the N-(4-azido-2,3,5,6-tetrafluorobenzoyl) moiety to reducing agents in aqueous buffers was also examined.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1021/bc00013a011 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Primate-specific 82-kDa choline acetyltransferase attenuates progression of Alzheimer's disease-like pathology in the APP knock-in mouse model.
Sci Rep
November 2024
Department of Physiology and Pharmacology, Schulich School of Medicine & Dentistry, Robarts Research Institute, University of Western Ontario, London, ON, N6A 5K8, Canada.
Alzheimer's disease (AD) is characterized by amyloidosis, neuroinflammation, cholinergic dysfunction and cognitive impairment. In AD, the cholinergic neuronal marker choline acetyltransferase (ChAT) is reduced and the primate-specific nuclear isoform, 82-kDa ChAT, is mislocalized to cytoplasm. Cell-based studies suggest a role for 82-kDa ChAT in regulating expression of AD-related genes with potential reductions in β-amyloid (Aβ) levels.
View Article and Find Full Text PDFValidation and characterization of research antibodies for Moesin, CD44, Midkine, and sFRP-1.
F1000Res
October 2024
Aging Institute, University of Pittsburgh, Pittsburgh, Pennsylvania, 15219, USA.
Article Synopsis
- - The TREAT-AD program aims to create reliable tools for testing hypotheses related to Alzheimer's disease, emphasizing the need for validated research antibodies used in experiments involving drug targets.
- - Researchers assessed several commercial antibodies targeting specific proteins (Moesin, CD44, Midkine, and sFRP-1) using Western blot analysis on brain tissues from a mouse model with Alzheimer's pathology.
- - The study found significant increases in the expression of these target proteins in the Alzheimer's model compared to control mice, confirming the antibodies' effectiveness for future research on Alzheimer's therapeutics.
Enhancing solution structural analysis of large molecular proteins through optimal stereo array isotope labeling of aromatic amino acids.
Biophys Chem
December 2024
Graduate School of Science and Engineering, Tokyo Metropolitan University, 1-1 Minami-ohsawa, Hachioji, Tokyo 192-0397, Japan. Electronic address:
The observation of side-chain peaks of aromatic amino acids is the prerequisite for a high-resolution three-dimensional structure determination of proteins by NMR. However, it becomes difficult with increasing molecular size due to an increased transverse relaxation and the control of the relaxation pathway is needed to achieve the observation. We demonstrated that even for the large molecular size of 82 kDa Malate synthase G (MSG), the aromatic C-H (CH) peaks of Tryptophan (Trp) and Phenylalanine (Phe) residues can be observed with high quality using a systematic stable isotope labeling scheme, Stereo-Array Isotope Labeling (SAIL) method.
View Article and Find Full Text PDFEvaluation of the prophylactic effect of egg yolk antibody (IgY) produced against the recombinant protein containing IpaD, IpaB, StxB, and VirG proteins from Shigella.
Mol Immunol
September 2024
Department of Biology, Faculty of Basic Sciences, Imam Hossein University, Tehran, Iran; Department of Medical Biotechnology and Nanotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Introduction: Shigellosis is a gastrointestinal disease causes high morbidity and mortality worldwide, however, there is no anti-Shigella vaccine. The use of antibiotics in shigellosis treatment exacerbates antibiotic resistance. Antibodies, particularly egg yolk antibody (IgY), offer a promising approach to address this challenge.
View Article and Find Full Text PDFStructural properties of glucan from Russula griseocarnosa and its immunomodulatory activities mediated via T cell differentiation.
Carbohydr Polym
September 2024
School of Life Sciences, Jilin University, Changchun 130012, China; Engineering Research Center of Chinese Ministry of Education for Edible and Medicinal Fungi, School of Plant Protection, Jilin Agricultural University, Changchun 130118, China. Electronic address:
The polysaccharide, RGP2, was isolated from Russula griseocarnosa and its immunostimulatory effects were confirmed in cyclophosphamide (CTX)-induced immunosuppressed mice. Following purification via chromatography, structural analysis revealed that RGP2 had a molecular weight of 11.82 kDa and consisted of glucose (Glc), galactose (Gal), mannose, glucuronic acid and glucosamine.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!